Bioceres Crop Solutions (NASDAQ:BIOX) Lowered to "Sell" Rating by Wall Street Zen

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research note issued to investors on Friday.

Separately, Oppenheimer lowered their price target on shares of Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating on the stock in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Bioceres Crop Solutions currently has an average rating of "Moderate Buy" and an average target price of $8.38.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX traded down $0.14 during midday trading on Friday, reaching $3.61. The company's stock had a trading volume of 86,494 shares, compared to its average volume of 184,247. The firm has a market capitalization of $226.38 million, a PE ratio of -25.78, a P/E/G ratio of 1.60 and a beta of 0.41. Bioceres Crop Solutions has a twelve month low of $3.51 and a twelve month high of $11.41. The stock has a fifty day moving average of $4.59 and a 200 day moving average of $4.94. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.22.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.08. The firm had revenue of $59.60 million for the quarter, compared to analyst estimates of $61.80 million. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative return on equity of 2.37%. On average, equities analysts expect that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Fourth Sail Capital LP lifted its holdings in Bioceres Crop Solutions by 25.1% during the first quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company's stock valued at $21,125,000 after purchasing an additional 928,708 shares in the last quarter. Long Focus Capital Management LLC lifted its holdings in Bioceres Crop Solutions by 11.4% during the first quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company's stock valued at $3,788,000 after purchasing an additional 85,000 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Bioceres Crop Solutions by 9.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company's stock valued at $3,761,000 after purchasing an additional 71,581 shares in the last quarter. Ballast Asset Management LP lifted its holdings in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after purchasing an additional 82,187 shares in the last quarter. Finally, Allianz Asset Management GmbH lifted its holdings in Bioceres Crop Solutions by 77.5% during the first quarter. Allianz Asset Management GmbH now owns 236,717 shares of the company's stock valued at $1,081,000 after purchasing an additional 103,337 shares in the last quarter. 17.68% of the stock is owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.